Uniunea Europeană -
română -
EMA (European Medicines Agency)
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - seruri imune și imunoglobuline, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - seruri imune și imunoglobuline, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
hetlioz
vanda pharmaceuticals netherlands b.v. - tasimelteon - tulburări de somn, ritm circadian - psiholeptice - hetlioz este indicat pentru tratamentul de tulburări de somn-veghe non-24 de ore (non-24) la adulţi complet orb.